Adam Feuerstein provided a list of 10 bio-pharma stocks with the highest short interest, according to S&P Capital IQ. The figures range from 22% of float for no. 10 InterMune (NASDAQ: ITMN) to 37.5% for no. 1 Sarepta Therapeutics (NASDAQ: SRPT).
With 1. 3 million shares of short interest at May 31 and a float of 115 million at March 31, short interest for Provectus is 1.1% of float.
I include the year-to-date stock chart of PVCT and the Nasdaq Biotechnology Index to be consistent with the illustrations provided in Feuerstein's article.